This news item from the Cornell Chronicle is about: Three Cornell researchers have been awarded a five-year Transformative Research Projects Award (T-R01) of approximately $3.04 million from the National Institutes of Health to fight cancer by targeting the regulation of metabolic enzymes. Richard A. Cerione, professor of pharmacology in the Department of Molecular Medicine, College of Veterinary Medicine, and of chemistry and chemical biology in the College of Arts and Sciences; Hening Lin, assistant professor of chemistry and chemical biology; and Robert S. Weiss, associate professor of molecular genetics in the Vet College, are working on the project, Succinylation and Malonylation as Novel Protein Modifications in Cancer. The research will focus on a new set of regulatory modifications that occur on proteins and which appear to be important to cancer progression, explain the researchers.